Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pep Amengual-Rigo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scientific Reports|June 24, 2021
NetCleave: an open-source algorithm for predicting C-terminal antigen processing for MHC-I and MHC-IIPep Amengual-Rigo, Victor Guallar
Bioinformatics (Oxford, England)|August 8, 2020
UEP: an open-source and fast classifier for predicting the impact of mutations in protein-protein complexesPep Amengual-Rigo, Juan Fernández-Recio, Victor Guallar
Polymers|October 21, 2020
Predicting Antibody Neutralization Efficacy in Hypermutated Epitopes Using Monte Carlo SimulationsPep Amengual-Rigo, Jorge Carrillo, Julià Blanco, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 31, 2023
NetCleave: An Open-Source Algorithm for Predicting C-Terminal Antigen Processing for MHC-I and MHC-IIRoc Farriol-Duran, Marina Vallejo-Vallés, Pep Amengual-Rigo, et al.
Scientific Reports|May 27, 2018
Multiple implications of an active site phenylalanine in the catalysis of aryl-alcohol oxidaseJuan Carro, Pep Amengual-Rigo, Ferran Sancho, et al.
Molecular Cell|October 2, 2018
Automated Design of Efficient and Functionally Diverse Enzyme RepertoiresOlga Khersonsky, Rosalie Lipsh, Ziv Avizemer, et al.
European Journal of Pharmacology|August 20, 2020
Survivin modulation in the antimelanoma activity of prodigininesPaola C Branco, Cristine A Pontes, Paula Rezende-Teixeira, et al.
Journal of Translational Medicine|January 4, 2024
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in miceAna Barajas, Pep Amengual-Rigo, Anna Pons-Grífols, et al.
Scientific Reports|January 3, 2026
A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodiesAnusuya Ramasubramanian, Brendan T Deveney, Sarah A Clark, et al.
Nature Communications|March 22, 2024
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infectionCarlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scientific Reports|June 24, 2021
NetCleave: an open-source algorithm for predicting C-terminal antigen processing for MHC-I and MHC-IIPep Amengual-Rigo, Victor Guallar
Bioinformatics (Oxford, England)|August 8, 2020
UEP: an open-source and fast classifier for predicting the impact of mutations in protein-protein complexesPep Amengual-Rigo, Juan Fernández-Recio, Victor Guallar
Polymers|October 21, 2020
Predicting Antibody Neutralization Efficacy in Hypermutated Epitopes Using Monte Carlo SimulationsPep Amengual-Rigo, Jorge Carrillo, Julià Blanco, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 31, 2023
NetCleave: An Open-Source Algorithm for Predicting C-Terminal Antigen Processing for MHC-I and MHC-IIRoc Farriol-Duran, Marina Vallejo-Vallés, Pep Amengual-Rigo, et al.
Scientific Reports|May 27, 2018
Multiple implications of an active site phenylalanine in the catalysis of aryl-alcohol oxidaseJuan Carro, Pep Amengual-Rigo, Ferran Sancho, et al.
Molecular Cell|October 2, 2018
Automated Design of Efficient and Functionally Diverse Enzyme RepertoiresOlga Khersonsky, Rosalie Lipsh, Ziv Avizemer, et al.
European Journal of Pharmacology|August 20, 2020
Survivin modulation in the antimelanoma activity of prodigininesPaola C Branco, Cristine A Pontes, Paula Rezende-Teixeira, et al.
Journal of Translational Medicine|January 4, 2024
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in miceAna Barajas, Pep Amengual-Rigo, Anna Pons-Grífols, et al.
Scientific Reports|January 3, 2026
A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodiesAnusuya Ramasubramanian, Brendan T Deveney, Sarah A Clark, et al.
Nature Communications|March 22, 2024
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infectionCarlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo, et al.
Pageof 2